immunAware ApS: Financial statements 2024
CVR: 39189135
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
immunAware ApS (CVR 39189135) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,057,989 and a net result of DKK -757,428 compared with DKK 1,308,604 the year before. That is a decrease of 25.4% compared with the year before. Equity in the 2024 report amounted to DKK 5,252,168. The solvency ratio was 90.8%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 4,057,989
- Profit/Loss
- DKK -757,428
- Equity
- DKK 5,252,168
- Total Assets
- DKK 5,782,303
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.1 mio. | -757 t. | 5.3 mio. | 8 |
| 2023 | - | 5.4 mio. | 1.3 mio. | 6.2 mio. | 6 |
| 2022 | - | 5.1 mio. | 1.6 mio. | 5 mio. | 5 |
| 2021 | - | 3.4 mio. | 1.2 mio. | 3.6 mio. | 3 |
| 2020 | - | 2.4 mio. | 1.2 mio. | 2.6 mio. | 1 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ImmunAware ApS has published its annual report for 2023. Gross profit came to DKK 5,438,301, and the net result was DKK 1,308,604.
About immunAware ApS
immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity in the 2025 report amounted to DKK 4,913,587.